Skip to main content

Table 5 Multi-level analysis evaluating the difference at T1 and T2 compared to T0 (baseline)

From: Experiences with tailoring of primary diabetes care in well-organised general practices: a mixed-methods study

 

T1

T2

Crude

Adjusted1

Crude

Adjusted1

OR (95% CI)

p

OR (95% CI)

p

OR / B (95% CI)

p

OR / B (95% CI)

p

Monitoring as recommended (OR)

0.7 (0.3–1.5)

0.35

0.7 (0.3–1.5)

0.34

0.2 (0.1–0.5)

< 0.001

0.2 (0.1–0.5)

< 0.001

DTSQ-Status2 (B)

N/A2

 

N/A

 

−1.8 (−2.8;-0.8)

< 0.001

− 1.6 (− 2.6;-0.6)

0.001

WHO-54 (B)

N/A

 

N/A

 

−1.3 (−5.5;2.8)

0.53

−1.3 (− 5.4; 2.9)

0.55

EQ-VAS5 (B)

N/A

 

N/A

 

−3.0 (− 7.1;1.2)

0.16

− 3.0 (− 7.1; 1.2)

0.16

  1. Abbreviations
  2. DTSQ Status: Diabetes Treatment Satisfaction Scale (all items except no. 2 and 3) WHO-5: World Health Organization Wellbeing Index-5
  3. EQ-VAS: EuroQol Visual Analogue Scale
  4. 1 Analysis adjusted for age, duration of diabetes, and gender.
  5. 2 N/A: not available.